Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.66
+0.215014.93%
Volume:210.32K
Turnover:327.41K
Market Cap:11.02M
PE:-0.35
High:1.67
Open:1.46
Low:1.40
Close:1.44
52wk High:12.56
52wk Low:0.6201
Shares:6.66M
Float Shares:5.84M
Volume Ratio:1.26
T/O Rate:3.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:2.38
PE(LYR):-0.20

Loading ...

FibroBiologics Faces Material Clinical Trial and Regulatory Risks That Threaten Commercialization Timeline and Long-Term Outlook

TIPRANKS
·
Aug 02

Fibrobiologics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) Estimate

Benzinga Earnings
·
Aug 01

Press Release: FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

Dow Jones
·
Aug 01

Fibrobiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

THOMSON REUTERS
·
Aug 01

Fibrobiologics - Interim Results for Cywc628 Trial Expected in Second Half of 2026

THOMSON REUTERS
·
Aug 01

Fibrobiologics Q2 FY26 Net Loss Narrows to $4.12 Million from Year-ago Quarter

Reuters
·
Aug 01

FibroBiologics Announces Special Stockholder Meeting

Reuters
·
Jul 31

Fibrobiologics Inc Expected to Post a Loss of 72 Cents a Share - Earnings Preview

Reuters
·
Jul 27

FibroBiologics Faces Nasdaq Delisting, Appeals Planned

TIPRANKS
·
Jul 25

Fibrobiologics Faces NASDAQ Delisting After Bid Price Stays Below $1

Reuters
·
Jul 25

Fibrobiologics Director Kathleen Hallisey Rubins Files Initial Beneficial Ownership Statement

Reuters
·
Jul 17

Fibrobiologics - Registers Resale of up to 12.53 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jul 10

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

TIPRANKS
·
Jul 09

Fibrobiologics Appoints Ex-nasa Astronaut Kate Rubins to Board

Reuters
·
Jul 09

Fibrobiologics Appoints Kathleen "kate" Rubins, Ph.d. to Board of Directors

THOMSON REUTERS
·
Jul 09

Fibrobiologics - Expects Cost Savings by Eliminating Additional Vial Manufacturing

THOMSON REUTERS
·
Jul 07

Fibrobiologics - Expects Sufficient Cywc628 Supply to Complete Dfu Clinical Trial

THOMSON REUTERS
·
Jul 07

Fibrobiologics Completes Manufacturing of Third Batch of Cywc628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

THOMSON REUTERS
·
Jul 07

FibroBiologics Secures New Private Placement Financing

TIPRANKS
·
Jun 30